Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells

BACKGROUND: Targeted co-delivery of siRNA and a chemotherapeutic drug is an attractive approach to cancer drug design and treatment. This study was carried out to design an anti-Mucin1 aptamer (Apt)-conjugated chitosan nanoparticle (NP) for targeted co-delivery of insulin-like growth factor receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafari, Reza, Zolbanin, Naime Majidi, Majidi, Jafar, Atyabi, Fatemeh, Yousefi, Mehdi, Jadidi-Niaragh, Farhad, Aghebati-Maleki, Leili, Shanehbandi, Dariush, Zangbar, Mohammad-Sadegh Soltani, Rafatpanah, Houshang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute 2019
Materias:
Full Length
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305820/
https://www.ncbi.nlm.nih.gov/pubmed/30041514
http://dx.doi.org/10.29252/.23.1.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305820/
https://www.ncbi.nlm.nih.gov/pubmed/30041514
http://dx.doi.org/10.29252/.23.1.21

Ejemplares similares